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Abstract
Plasma tachykinin levels are known to be altered with
sexual acyclicity and loss of reproductive function.
Ovulatory dysfunction, as seen in postmenopausal
women, is also often encountered in hypothyroid
patients. To know the involvement of different
tachykinin genes in hypothyroidism-associated
reproductive disorders, we performed DD-PCR with
the pituitary RNA of control and hypothyroid rats to
see the differentially expressed gene profile.
Subsequently, we selected a few clones, tachykinin
being one of them. Since its expression was up
regulated in hypothyroidism as it does in the sexually
acyclic females, we wanted to correlate these two
phenomena with hypothyroidism associated
reproductive disorders. We observed differential
expression of tac2 along with other tk genes and their
receptors in rat pituitary and ovary, which suggests
that hypothyroidism affects the expression of these
genes in these tissues. The experiments were
repeated in ovarian tissue obtained at surgery from
hypothyroid human patients, which showed similar
expression pattern of TAC3 (equivalent to rat tac2)
and their receptors as in rat ovary. Significant
reduction of tac2 expression in reproductively less
active rat ovary suggests the association of tac2 with
reproductive senescence. Our results suggest that
decline in reproductive function in hypothyroidism is
associated with altered expression level of tac2 and
its receptors. Further investigation in this area could
elucidate the possible mechanism of tachykinins’
involvement in loss of sexual cyclicity and other
reproductive disorders associated with
hypothyroidism.
Introduction
The tachykinins (tks) are bioactive peptides and are
widely distributed within the mammalian peripheral and
central nervous system and play a well-recognized role
as excitatory neurotransmitter. The mammalian tks are
encoded by three different genes, termed as pre-
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protachykinin TAC1, TAC3 and TAC4 according to the
Human Genome Organization (HUGO). This
nomenclature replaces the previously used terms PPT-
A/PPT-1 (TAC1), PPT-B/PPT-II (TAC3) and PPT-C
(TAC4) [1]. Tac1, the first gene that was cloned from
bovine brain was initially believed to have two splice
variants, one containing substance P (SP /tac1) and the
second containing Neurokinin A (NKA/tac2) [2]. Later,
it was realized that a discrete genomic segment encoded
NKA by alternative RNA splicing of the same gene to
yield α-tac1 and β-tac1 [3]. TAC1 expression has been
found in all human tissues, particularly the whole brain,
heart, colon, spleen, fetal brain and mammary gland except
for the placenta, a tissue not innervated by the peripheral
nervous system [4, 5]. The classification of the mammalian
tks has been mentioned in Table 1 [2, 4, 6-13].
Tk exerts its effects on target cells by at least three
specific guanine nucleotide coupled receptors, the
tachykinin receptors [NK-1R, -2R and -3R encoded by
Tacr1, -r2 and -r3] [14]. Each tk appears to preferentially
activate a distinct receptor, although at low ligand
concentration. Tacr1 is preferentially activated by SP, tacr2
by NKA, and tacr3 by NKB [15]. The conserved
carboxyl terminal domain of tks is essential for receptor
activation, whereas their amino terminal dictates receptor
specificity. However, tks are not highly selective to bind
and activate their receptors at high ligand concentration.
Tks are also found in endocrine glands and have
been shown to exert paracrine actions on the secretion
of hormones with potent stimulatory activity on the
contraction of smooth muscle [16]. The possible presence
of tk in the oocytes and the surrounding cells may be a
contributing factor to stimulate the contraction of smooth
muscle after the oocyte is shed and picked up by the
fallopian tube; it will help transport the cell inside the tubes
[17]. In mammals, the most abundant tks are SP, NKA,
NPK, NPγ and NKB, which act on the hypothalamo-
pituitary-gonadal axis to regulate reproductive functions
[18-20]. It is widely known that chronic estradiol-induced
loss of LH-surge causes loss of sexual cyclicity [21].
Other reports suggest that estradiol increases
hypothalamic levels of SP and NKA [22] and also
substance P receptor gene expression in pancreatic acinar
cells [23]. The increased levels of hypothalamic NKA,
SP and NKB in aged female rats and decreased level of
pineal NKA concentrations suggest that such up- and
down regulations may have some relationship with the
loss of sexual cyclicity due to aging. It seems evident,
that aging alters the regulation of the tk content in CNS,
but this influence was specific for each tissue [24, 25]. In
ovary, both nervous tissue and the granulosa, luteal and
interstitial cells express tk-encoding genes [26]. Relatively
few studies have been the focus of the possible direct
intra-ovarian role of tk [27].
 To study the differentially expressed gene profile in
hypothyroidism, we performed DD-PCR with two major
centers of reproductive axis i.e pituitary and ovary. We
performed DD-PCR with pituitary and ovarian RNA and
subsequently selected a few clones, tachykinin1 (tac1)
being one of them, obtained from pituitary RNA.
Hypothyroidism is associated with different types of
reproductive dysfunction, including ovarian atrophy [28],
disturbed folliculogenesis, anovulation [29], infertility and
increased frequency of recurrent unexplained foetal loss
[30]. Since tks are intraovarian modulators as well as
they likely exert a paracrine modulatory activity on the
secretion of hormonal steroids [31], their altered
expression in both pituitary and in ovary could influence
the steroid hormone release via autocrine and paracrine
functions. In our earlier report we showed the involvement
of various genes, including lysyl hydroxylase, matrix
metalloproteases, collagens in hypothyroid associated
reproductive dysfunction [32, 33]. In the present study
we wanted to investigate whether tks are also involved
in hypothyroid associated ovarian dysfunction or not and
this would be another aspect to study its regulatory
mechanism. We showed the status of tac1, tac2 and their
receptors in hypothyroid rat ovary and pituitary. We also
showed that tac2 expression was significantly reduced in
reproductively less active rat ovary, suggesting its
association with reproductive senescence. We did not
obtain tac1 expression in the ovary of 4-weeks old rat
before 6m of age; hence performed the detail and
subsequent studies with tac2, which was expressed in
both pituitary and ovary at all ages under study. We were
able to show the expression of TAC3 (equivalent to rat
tac2) gene and its receptors in ovaries of human
hypothyroid patients to satisfy its clinical value.
Cumulatively, our results indicate that altered expression
of tac2 attribute to the reproductive senescence due to
hypothyroidism.
Table 1. Classification of the mammalian tachykinins
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Materials and Methods
Animals and treatment
As described previously, newborn pups were rendered
hypothyroid (hypothyroid rats) through their mother’s milk
because the mothers take 0.02 % 6-N-propyl-2-thiouracil (PTU;
Sigma, St. Louis, MO) with the drinking water [32, 34]. The
hypothyroid pups were given intra-peritoneal T3 injection at a
dose of 15µg/ 100 gm body weight [35]. For T3 and TSH
measurement, serum from 10 individual rats was collected and
the mean value of 10 samples is presented. We strictly followed
all details of the animal protocol approved by Institutional
Animal Ethics Committee during the experiments. The rats
mentioned as +PTU+T3 were i.p injected daily with T3 (15 µg/
100g body wt) in hypothyroid rats. Here the rats were injected
from d15 of their birth for 15 consecutive days. After that blood
was collected from each set and serum samples were prepared
from control, hypothyroid and experimental rats followed by
RIA and ELISA for T3 and TSH assay respectively (Table 2).
For RNA  work with ovary and pituitary, 26d old rats were
treated with pregnant mare’s serum gonadotropin (PMSG) [32].
After 48hrs of this treatment, the rats were anaesthetized,
dissected and respective tissues were collected and washed in
PBS and RNA isolation was followed.
Human sample collection
The patients gave written informed consent for the
studies, as required by the Ethics committee of the Institute of
Post Graduate Medical Education and Research, Kolkata. The
study group consisted of 6 hypothyroid and 6 non-hypothyroid
(control) subjects. Their age was 20-50yrs. All subjects were
apparently healthy and did not take any regular medication.
Blood samples were collected from each group and isolated
serum samples were subjected to T3 and TSH assay by RIA
and ELISA respectively (Table 2). Ovary samples were collected
from control and hypothyroid human patients undergoing
oophorectomy with hysterectomy for control of menorrhagia
and the tissue bits were collected in TRI-reagent (RNA isolation
solution), for further analysis. Venous blood samples were
obtained for the measurement of plasma T3 and TSH.
Differential Display PCR (DD-PCR)
Differences in patterns of gene expression were
determined using DD-PCR kit provided by Clonetech (Palo
Alto, CA, USA). Briefly, cDNA was synthesized from total RNA
(2µg) isolated from rat pituitary using cDNA synthesis primer
provided by the vendor. The resulting cDNAs were amplified
by PCR with a 25-nt oligomer of random sequence and with
oligo dT primers. A total reaction of 20 µl contained 1X PCR
buffer (10mM Tris-HCl, pH 8.3, 50mM KCl), 3mM MgCl2, 200
µM dNTPs (along with [α-P32]deoxy-ATP, and 1 unit of Taq
DNA Polymerase (Clonetech). Amplification was performed
using the following protocol- 1 cycle at 94°C for 5min, 40°C for
5 min and 68°C for 5min; then 2 cycles at 94°C for 2min, 40°C for
5min and 68°C for 5min; and then 23 cycles at 94°C for 20sec,
60°C for 30sec and 68°C for 2min. Amplified products were
resolved on a 5% denaturing polyacrylamide gel. Auto-
radiographs of dried gels were prepared by overnight exposure
to BioMAX MR film (Kodak, Rochester, NY). Bands
corresponding to differentially expressed mRNAs were excised
from the acrylamide gel, reamplified using PCR and then cloned
into the T/A cloning vector using the InsT/A cloning kit (MBI
Fermentas, Hanover, MD).
Radio Immuno Assay (RIA)
In rats and human patients, plasma T3 was determined by
RIA using T3 RIA kit as previously described (Riak-4
radiopharmaceuticals operations, BRIT, BARC, India) [32, 36]
The sensitivity of T3 was 0.24 ng/ml of the sample based on
90% B/B0 intercept.
ELISA
In rats and human patients, ELISA was performed for
serum TSH using Pathozyme TSH kit (Omega Diagnostics Ltd,
UK) as described previously [32]. The minimum detectable
concentration of TSH by Pathozyme TSH kit was estimated to
be 0.2 µIU/ml
RNA isolation
Total RNA was isolated from rat ovary and pituitary (from
control, hypothyroid group and T3-injected hypothyroid rats)
and also from human ovarian tissue using RNA isolation reagent
(TRI-Reagent, Sigma) following to the manufacturers protocol
[32].
Northern Blot analysis
Northern blotting and hybridization was performed
following the methods described earlier [37]. Briefly, 10µg of
total RNA, isolated from pituitary, was loaded in each lane of
1% formaldehyde-agarose gel, electrophoresed, and transferred
Table 2. Serum samples were collected from control,
hypothyroid and T3-treated hypothyroid rats and T3, TSH were
assayed as mentioned in the methods section and are
represented in the table. Similarly serum T3 and TSH levels
were assayed from normal and hypothyroid human patients
and the mean values are represented in the table.
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to a nylon membrane (Millipore, USA) by capillary transfer
method. Pre-hybridization was allowed for 2hours in the buffer
containing 6 X SSC with 50% formamide, 1 X Denhardt’s
solution, 100 µg/ml salmon sperm DNA and 1% SDS at 42°C.
Hybridization was carried out in the same condition with the
[α-32P] dATP-labelled tachykinin gene fragment for 18h.Then
the membrane was washed for 90min at 65°C in 2 X SSC
containing 0.1% SDS with subsequent three changes of buffer.
The hybridized membrane was exposed to Kodak X-ray film
and kept at -80°C as per required exposure time. RNA molecular
size markers (0.2kb-6 kb) used in the test was purchased from
MBI Fermentas.
Reverse Transcription-Polymerase Chain Reaction
First strand cDNA synthesis was carried out with 2 µg
total RNA isolated from rat pituitary and ovary as well as from
human ovaries using Revert Aid M-Mulv Reverse Transcriptase
(MBI Fermentas), following the manufacturer’s instruction. Into
the tube, oligo (dT)18 primer, RT reaction buffer, RNase inhibitor,
dNTPs were mixed (final volume 20µl) and incubated at 42°C
for 1h for the first strand cDNA synthesis. 2µl of the synthesized
cDNA was used as template for semi-quantitative PCR with
gene specific primers and relative expression was observed
with GAPDH primer (38). A 50µl PCR volume was made by
adding 2.5U Taq DNA polymerase (Invitrogen, USA), to a PCR
mixture containing 1X reaction buffer [50 mM KCl, 10 mM Tris-
HCl (pH 8.3), 0.1% Triton-X-100 and 2.5 mM MgCl2], 200 µM of
each dNTPs (Sigma, USA), 0.4 pmol of each primer (sense and
antisense). The PCR was performed with initial denaturation at
94°C for 5min, and then 35 cycles of denaturation at 94°C for
30sec, annealing at specific temperature for each set of primers
for 30sec, extension at 72°C for 35sec, final extension at 72°C
for 10min in the last cycle (Perkin-Elmer 9700). The RT-PCR
products were cloned and sequenced. The primers used for
RT-PCR and the amplicon sizes are listed in Table-3. The
expression profile of different tachykinin genes and their
receptors was also verified by real time quantitative RT-PCR
(Q-PCR) method and the similar kind of expression profile was
observed here. We have not incorporated the Q-PCR data in
this report to avoid redundancy.
Table 3. The oligonucleotide primers and the respective amplicon sizes of different genes used in the semi quantitative RT-
PCR has been listed in the table.
Sequencing and analysis
Sequencing of the plasmid DNA and the PCR products
was done by ABI Prism Automatic DNA Sequencer (Perkin
Elmer). Sequence alignment and data analysis was done through
BLAST search from NCBI GenBank. [39].
Statistical analysis
All data are expressed as the mean ± SD, statistical
analysis, which was performed by Student’s t-test. P<0.05 was
considered to be significant. The experiments were repeated at
least three times in duplicate unless otherwise stated.
Results
Identification of Tachykinin clone by DD-PCR
We performed DD-PCR with RNA isolated from
the pituitaries of control and hypothyroid rats. We identified
a number of up- and down regulated cDNA clones in
hypothyroid condition (data not shown). The differentially
expressed cDNAs thus obtained were cloned and then
sequenced. One of such clones happened to be tachykinin
(tac1).
Differential expression of tac1 in pituitary of
hypothyroid and T3-supplemented hypothyroid
rats
To reconfirm the authenticity of the DD-PCR result,
we performed Northern hybridization with control and
hypothyroid pituitary RNA using tac1 cDNA as a probe
(Fig. 1a). Like DD-PCR results, the expression level of
tac1 in hypothyroid pituitary was markedly higher
compared to control. In Fig. 1 (a), the rRNA bands of
control and hypothyroid pituitary indicate equal loading in
both lanes.
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Fig. 1. Differential expression of tac1 in pituitary of hypothyroid and T3 supplemented hypothyroid rats. RNA was isolated from
control (C) and hypothyroid (H) rat pituitary and the isolated RNAs were electrophoresed on agarose gel and Northern hybridized
with radio-labeled tac1 cDNA fragment as probe. The hybridized band and the ethidium bromide stained rRNA bands (as loading
control) have been shown (Fig. 1a). RT-PCR was performed with pituitary RNA isolated from control (C), hypothyroid (H), and T3-
injected hypothyroid (HT) rats using gene specific primers for tac1 and GAPDH (Fig 1b). In the lower panel of the RT-PCR data,
scanning data of the respective band intensities have been shown, where pixel value of each band was calculated by the ImageJ
software. In tac1 RT-PCR result, average pixel value of both the bands has been represented. The above experiments were
performed three times in duplicate and the scanning data is the mean ± SD. *P < 0.05.
RT-PCR was performed with pituitary RNA isolated
from control (C), hypothyroid (H) and T3-injected
hypothyroid rats (HT) using gene specific primers for
tac1 and GAPDH. As shown in Fig. 1(b), the expression
levels of tac1 was significantly higher in hypothyroid
condition compared to control. Upon T3 supplementation
to the hypothyroid rats, the expression levels of tac1
reverted back to the normal level. The double band
obtained in this RT-PCR data suggests the amplification
of tac1 splice variants in this tissue. GAPDH expression
level was unaltered under the above-mentioned conditions.
Differential expression of tac2 and its receptor
in pituitary of hypothyroid and T3-supplemented
hypothyroid rats
RT-PCR was performed with pituitary RNA from
control (C), hypothyroid (H) and T3-injected hypothyroid
(HT) rats using gene specific primers of tac2 and also
with tacr3 and GAPDH. In Fig. 2, the result shows that
tac2 was significantly down regulated in hypothyroid
condition. The expression level of tac2 did not revert back
to its normal level in T3-injected hypothyroid pituitary. The
expression level of tacr3 was markedly induced under
hypothyroid condition. Upon T3-supplementation to the
hypothyroid rats, the expression of this receptor had a
tendency to revert back to the control level. GAPDH
expression level was unaltered under the above-mentioned
conditions.
Differential expression of tac2 and its receptor
in ovary of hypothyroid and T3-supplemented
hypothyroid rats
RT-PCR was performed with ovarian RNA from
control (C), hypothyroid (H) and T3-injected hypothyroid
(HT) rats using gene specific primers of tac2 and also
with tacr3 and GAPDH. In Fig. 3, the result indicates, as
in pituitary, tac2 is significantly down regulated in
hypothyroid ovary and its decreased expression level did
not revert back to its normal value even after T3
supplementation. The expression level of tacr3 was down
regulated in hypothyroid ovary and upon T3
supplementation to the hypothyroid rats, the expression
of tacr3 reverted back to its normal value. GAPDH
expression level was unaltered under the above-mentioned
conditions.
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The expression levels TAC3 (equivalent to rat
tac2) and its receptor in hypothyroid human
ovary
RT-PCR was performed with ovarian RNA isolated
from normal (C) and from hypothyroid (H) human patients
undergoing oophorectomy, using gene specific primers
Fig. 2. Differential expression of tac2 and its receptor in pituitary of hypothyroid and T3-supplemented hypothyroid rats. RT-
PCR was performed with pituitary RNA isolated from control (C), hypothyroid (H), and T3- supplemented hypothyroid (HT) rats
using gene specific primers for tac2, tacr3 and GAPDH. In the lower panel of the RT-PCR data, scanning data of the respective
band intensities have been shown, where pixel value of each band was calculated by the ImageJ software. The above experiments
were performed three times in duplicate and the scanning data is the mean ± SD. *P < 0.05.
Fig. 3. Differential expression of tac2 and its receptor in rat ovary of hypothyroid and T3-supplemented hypothyroid rats. RT-
PCR was performed with ovarian RNA isolated from control (C), hypothyroid (H) and T3-supplemented hypothyroid (HT) rats
using gene specific primers for tac2, tacr3 and GAPDH. Lower panel of each RT-PCR data represents scanning data of the
respective band intensities, where pixel value of each band was calculated by the ImageJ software. The above experiments were
performed three times in duplicate and the scanning data is the mean ± SD. *P < 0.05.
of TAC3 (equivalent to rat tac2), TACR3 and GAPDH.
As shown in Fig. 4, TAC3 expression level was down
regulated in hypothyroid patients, although not very
significantly. The expression level of TACR3 was induced
in hypothyroid human ovary.
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Fig. 4. Differential expression of TAC3 (equivalent to tac2 in rat) and its receptor in the ovary of hypothyroid patient. RT-PCR
was performed with ovarian RNA isolated from control (C) and hypothyroid (H) human subjects (undergoing oophorectomy)
using gene specific primers for TAC3, its receptor TACR3 and GAPDH. In the lower panel of the RT-PCR data, scanning data of
the respective band intensities have been shown, where pixel value of each band was calculated by the ImageJ software. The
above experiments were performed three times in duplicate and the scanning data is the mean ± SD. *P < 0.05.
Fig. 5. The differential
expression of tac2 in the rat
ovaries of different age-
groups. RT-PCR was
performed with ovarian
RNA isolated from different
age group of rats i.e, 1m, 4
m, 6 m and 12 m using gene
specific primers for tac2
and GAPDH. Lower panel
of each RT-PCR data,
scanning data of the
respective band intensities
have been shown where
pixel value of each band
was calculated by the ImageJ software. The above experiments were performed three times in duplicate and the scanning data is
the mean ± SD. *P < 0.05.
Differential expression of tac2 in the rat ovaries
of different age-groups
RT-PCR (Fig. 5) was performed with ovarian RNA
isolated from 1-, 4-, 6- and 12months old rats and the
result shows that the tac2 expression level was increased
gradually from 1 m of age onwards and the value was
maximum at 6 m. But at 12m, its expression became
significantly less. However, GAPDH expression was
unaltered under the above-mentioned conditions.
Differential expression of tac4 in pituitary and
ovary of hypothyroid and T3-supplemented
hypothyroid rats
We wanted to check the expression level of other tk
gene in rat pituitary and ovary. RT-PCR was performed
with RNA isolated from control (C), hypothyroid (H) and
T3-supplemented hypothyroid (HT) rats using gene
specific primers of tac4 and GAPDH (Fig. 6). The RNAs
were isolated  from rat pituitary and ovary. Tac4 gene
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expression, however, was significantly increased in
hypothyroid condition in both pituitary (a) and ovary (b).
In both the tissues, expression levels of these genes were
significantly reduced upon T3-supplementation to
hypothyroid rats, whereas GAPDH expression was
unaltered under these conditions.
Discussion
The presence of tachykinins have been
demonstrated in endocrine glands, where they likely exert
a paracrine modulatory effect on hormonal secretions and
the conceived dogma that the tks are exclusively restricted
to nervous tissue thus has been challenged [26]. Tks of
both neuronal and non-neuronal (like ovarian granulosa
Fig. 6. The differential expression
level of tac4 gene in pituitary and
ovary of hypothyroid and T3-
supplemented hypothyroid rats. In
Fig (a) and (b), RT-PCR was
performed using gene specific
primers for tac4 and GAPDH with
pituitary and ovarian RNA
respectively isolated from control (C),
hypothyroid (H) and T3-injected
hypothyroid (HT) rats. In the lower
panel of each RT-PCR data, scanning
data of the respective band
intensities have been shown, where
pixel value of each band was
calculated by the ImageJ software.
The above experiments were
performed three times in duplicate
and the scanning data is the mean ±
SD. *P < 0.05.
and luteal cells) origin are differentially expressed in
various types of reproductive cells and may play role in
female reproductive function [17]. Tks have a direct
contractile effect in uterine smooth muscle [40] and have
been implicated in menstrual and pregnancy related
disorders [41-46].
Various types of reproductive disorders are
associated with hypothyroidism. Differential expression
of different tk genes has relationship with the loss of
sexual cyclicity [25]. As similar reproductive failure is
prevalent in hypothyroidism, we wanted to correlate the
differential expression of tk with reproductive malfunction
in hypothyroidism and identified the up regulation of tac1
gene in the pituitary of hypothyroid rat. Previous report
suggests that hypothyroidism due to thyroidectomy
produced large increases in the preprotachykinin-A
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Fig. 7. The scheme shows that the expression of different tachykinin genes is affected in sexual acyclicity caused by different
factors including hormones, like estradiol, aging and hypothyroidism. The upward arrows indicate up regulation and the downward
arrows indicate down regulation of a particular tachykinin gene.
mRNA level in pituitary, whereas with T4 replacement
the mRNA level was much decreased [47]. Hence our
model (hypothyroidism caused by PTU treatment) is
supported by similar results obtained in hypothyroidism
made by thyroidectomy. In addition to this, existing report
suggests that rats infused with SP show an increased
serum level of TSH [48]; whereas we observed that in
hypothyroid rats (where TSH was increased), SP (tac1)
level was also increased in pituitary. Therefore, these two
observations suggest that tac1 and TSH are inducible to
each other. In ovary, tac1 expression was not detected
before 6m of age, whereas tac2 expression was detected
in both the tissues at the age of 4-weeks. Therefore, to
get a complete and useful data on comparative expression
profiles in two major centers of reproductive axis, i.e.
pituitary and ovary and subsequently to have a clear idea
about the inter-relationship between tk and
hypothyroidism-associated reproductive disorders; we
focused our study mostly on tac2.
In this report we show that tac2 expression is
significantly down regulated in hypothyroid condition both
in pituitary and in ovary, which did not revert back upon
T3-supplementation. This data reinforces a recently
published result, which suggests that neonatal treatment
with capsaicin (induces release and depletion of SP in
female rats and mice), resulted in decreased reproductive
success compared to control [17, 49-52]. According to
the order of potency of the tk receptors, NKB activates
tacr3 most compared to tacr1 and -r2 [26]. The
expression level of tacr3 remained significantly low in
hypothyroid rat ovary and was recovered after T3-
supplementation. As tac2 expression did not recover, it is
expected that even after T3-supplementation the tac2 or
more precisely NKB mediated pathway in ovary and in
pituitary remains affected which might exert the decline
in reproductive success. Similarly, in hypothyroid human
patients also TAC3 (equivalent to tac2 in rat) gene was
down regulated, whereas TACR3 was up regulated. Tacr1
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and -r2 expression level varies in rat ovary and pituitary
and also in human subjects, which suggests that expression
of other tk receptors also affected due to hypothyroidism
(data not shown). The differential expression status of
various tk genes in PTU-induced hypothyroidism or in
T3-supplemented hypothyroid ovaries and pituitaries could
be addressed in analogy with the effect of PTU on
parathyroid. Previous reports suggest that prolonged PTU
treatment i.e., prolonged TSH stimulation could lead to
hyperparathyroidism and that is not reversed even with
supplementation with thyroxin [53]. Again the specific
effect of PTU could be endorsed considering another
aspect where it is reported that neuropeptides containing
nerve fibers are localized to parathyroid gland. The report
suggests a novel neuroendocrine pathway whereby SP
regulates PTH secretion through NK-1 receptors [54].
Although we did not check tac1 expression level in
parathyroid gland, it is obvious that tac1 is upstream of
PTH secretion. Since our observation suggests that tac1
expression level is increased in hypothyroid rat pituitary,
it may induce PTH secretion.
Aging of CNS was associated with widespread
changes in TK expression [55]. Here we investigate the
association of altered expression of tac2 with reproductive
senescence. The first overt sign of reproductive aging in
female rats occurs around 8-12 months of age, when the
preovulatory LH surge becomes attenuated and delayed;
it probably results from a decrease in response of the
hypothalamic-pituitary axis to the positive feedback action
of estradiol. Around 9-11m of age female rats cease
cycling altogether [21]. Our data shows that at 12m, when
the reproductive efficiency falls, tac2 expression was
reduced significantly in rat ovary. The alteration in tac2
may have implications in the pathophysiology of the elderly,
as the increased NKB gene expression in the
hypothalamus of postmenopausal women is secondary
to estrogen withdrawal [55]. Again, pineal NKA
concentrations markedly decreased when the female rats
reached acyclicity which may be due to the senescence
of the neuroendocrine-reproductive axis [56]. Hence,
decline in reproductive function in acyclic aged female
rats was associated with both increase and decrease of
tks in hypothalamus and pineal gland respectively [24,
56]. Therefore, as we have shown, the decreased tac2
expression associated with sexual acyclicity due to
hypothyroidism is supported by the fact that tac2 is
similarly down regulated in aging-induced sexual acyclicty.
Since tac4 is associated with pregnancy as well as normal
and premature labor [40], its altered expression could
affect these physiological phenomena. The tac4
expression profile in pituitary and ovary shows that in
these tissues its expression was induced in hypothyroid
condition, suggesting its involvement in hypothyroid
associated reproductive disorders.
We demonstrate here that expressions of tac2 along
with other tk genes and their receptors are affected due
to hypothyroidism. We have also shown the decreased
tac2 expression with the loss of reproductive efficiency.
The steroid hormone-induced sexual senescence has been
shown to play a major role in controlling the expression
of different tk genes in different tissues. The expression
of different tk genes is affected in sexual acyclicity caused
by different factors including hormones, like estradiol,
aging and hypothyroidism and that has been represented
as a schematic diagram (Fig. 7). It is yet to be ascertained,
whether altered expression of tks and their receptors are
the primary cause of reproductive senescence. If so, in
future, the modulation of expression of the important tks
at the transcriptional and translational level may be
performed with specific and selective agents to combat
different reproductive disorders associated with
hypothyroidism and aging. Further extensive study is
needed to unravel the specific role of tachykinin family
genes in reproductive senescence caused by
hypothyroidism and aging.
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